Could a switch to analogue insulin reduce dangerous low blood sugar in kids with diabetes?
Disease control
Completed
This completed Phase 4 trial enrolled 400 youth aged 7-25 with type 1 diabetes in low-resource settings. It compared insulin glargine (a long-acting analogue) to standard human insulin (NPH or premixed) to see if glargine reduces serious hypoglycemia or improves time in blood sug…
Phase: PHASE4 • Sponsor: Jing Luo • Aim: Disease control
Last updated Jun 26, 2026 16:29 UTC